Leukemoid reaction response to chemotherapy and radiotherapy in a patient with cervical carcinoma
β Scribed by H. S. Nimieri; S. N. Makoni; F. H. Madziwa; D. S. Nemiary
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 85 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. The locoregional failure rate remains high in advanced cervical carcinoma. Chemotherapy (CT) was added to radiotherapy (RT) in order to increase disease control and to improve 5-year survival. ## METHODS. CT+RT included cisplatin administered 100 mg/mz, d.1 plus 5-flUOrOuracil 10
## Abstract We report the serial cytogenetic study of a patient with Down syndrome who experienced a congenital leukemoid reaction, underwent a spontaneous remission within four months, and subsequently developed acute myeloid leukemia at 16 months. A blood chromosome study to rule out Down syndrom
## Background and Objectives: The extreme drug resistance (EDR) assay is an in vitro chemoresistance assay performed on tumor samples grown in culture and is claimed to predict drugs unlikely to produce response. Its clinical value in patients with epithelial ovarian cancer (EOC) has recently been